• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Clinical uses of low-molecular-weight heparins.

作者信息

Aguilar D, Goldhaber S Z

机构信息

Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.

出版信息

Chest. 1999 May;115(5):1418-23. doi: 10.1378/chest.115.5.1418.

DOI:10.1378/chest.115.5.1418
PMID:10334162
Abstract
摘要

相似文献

1
Clinical uses of low-molecular-weight heparins.
Chest. 1999 May;115(5):1418-23. doi: 10.1378/chest.115.5.1418.
2
Clinical and economic impact of low-molecular weight heparins in managed care. Introduction.
Am J Manag Care. 2000 Nov;6(20 Suppl):S1024-5.
3
Treat DVT with low molecular weight heparin.使用低分子量肝素治疗深静脉血栓形成。
Nurse Pract. 2003 Oct;28(10):22-9; quiz 30-1. doi: 10.1097/00006205-200310000-00010.
4
[Treatment and prophylaxis of deep venous thrombosis with low molecular weight heparins (meta-analysis of clinical trials)].[低分子量肝素治疗和预防深静脉血栓形成（临床试验的荟萃分析）]
Medicina (Kaunas). 2003;39(4):352-8.
5
Low-molecular-weight heparin in the treatment of pulmonary embolism.低分子量肝素治疗肺栓塞
Semin Vasc Surg. 2000 Sep;13(3):189-93.
6
Evidence-based management of deep vein thrombosis and pulmonary embolus.
Clin Med (Lond). 2001 Nov-Dec;1(6):438-41. doi: 10.7861/clinmedicine.1-6-438.
7
[Acute venous thrombosis: new directions in prophylaxis and treatment].[急性静脉血栓形成：预防与治疗的新方向]
Khirurgiia (Mosk). 1998(12):60-3.
8
[Low molecular weight heparins: mechanisms of action and pharmococynetics. Clinical advantages over the classic unfractioned heparins].[低分子量肝素：作用机制与药代动力学。相较于传统普通肝素的临床优势]
Rev Port Cir Cardiotorac Vasc. 2003 Apr-Jun;10(2):61-7.
9
Venous thromboembolism in the pregnant woman.孕妇的静脉血栓栓塞症
J Reprod Med. 2003 Nov;48(11 Suppl):921-9.
10
[Low-molecular weight heparins in the prophylaxis and treatment of pulmonary thromboembolism].[低分子量肝素在肺血栓栓塞症的预防和治疗中的应用]
Rev Esp Cardiol. 2001 Sep;54(9):1121-2. doi: 10.1016/s0300-8932(01)76463-9.

引用本文的文献

1
[Advances in heparin structural analysis by chromatography technologies].[色谱技术在肝素结构分析中的进展]
Se Pu. 2023 Feb;41(2):107-121. doi: 10.3724/SP.J.1123.2022.07020.
2
Clinical Feasibility of Monitoring Enoxaparin Anti-Xa Concentrations: Are We Getting It Right?监测依诺肝素抗Xa因子浓度的临床可行性：我们做对了吗？
Hosp Pharm. 2017 Mar;52(3):214-220. doi: 10.1310/hpj5203-214.
3
Enoxaparin vs. unfractionated heparin for anticoagulation during continuous veno-venous hemofiltration: a randomized controlled crossover study.
依诺肝素与普通肝素用于持续静脉-静脉血液滤过抗凝的随机对照交叉研究
Intensive Care Med. 2007 Sep;33(9):1571-9. doi: 10.1007/s00134-007-0719-7. Epub 2007 Jun 12.
4
Fondaparinux sodium.磺达肝癸钠
Drugs. 2002;62(11):1673-85; discussion 1686-7. doi: 10.2165/00003495-200262110-00007.
5
Low-molecular-weight heparin for the treatment of patients with mechanical heart valves.低分子量肝素用于机械心脏瓣膜患者的治疗。
Clin Cardiol. 2002 Jul;25(7):323-7. doi: 10.1002/clc.4950250704.